https://orcid.org/0000-0002-8574-3297
References
- Scorza FA, de Almeida ACG, Cysneiros RM, et al. Sudden death in Parkinson’s disease: treating hypertension in the elderly is essential. Exp Opin Pharmacother. 2021;(to be updated).
- Scorza FA, Do Carmo AC, Fiorini AC, et al. Sudden unexpected death in Parkinson’s disease (SUDPAR): a review of publications since the decade of the brain. Clinics. 2017;72(11):649‐651.
- Scorza FA, Fiorini AC, Scorza CA, et al. Cardiac abnormalities in Parkinson’s disease and Parkinsonism. J Clin Neurosci. 2018;53:1‐5.
- Chen J, Zhang C, Wu Y, et al. Association between hypertension and the risk of Parkinson’s disease: a meta-analysis of analytical studies. Neuroepidemiology. 2019;52(3–4):181–192.
- Jost WH. Autonomic dysfunction in Parkinson’s disease: cardiovascular symptoms, thermoregulation, and urogenital Symptoms. Int Rev Neurobiol. 2017;134:771–785.
- Jost WH. What are the considerations for anti-hypertensive treatment in patients with Parkinson’s disease? Expert Opin Pharmacother. 2020;21(10):1127–1130.
- Marxreiter F, Winkler J. Vascular parkinsonism. Fortschr Neurol Psychiatr. 2016;84(Suppl 1):S8–S13.
- Hou L, Li Q, Jiang L, et al. Hypertension and diagnosis of Parkinson’s disease: a meta-analysis of cohort studies. Front Neurol. 2018;9:162.
- Qiu C, Hu G, Kivipelto M, et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the national FINRISK study. Hypertension. 2011;57(6):1094–1100.
- Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.
- Abugroun A, Taha A, Abdel-Rahman M, et al. Cardiovascular risk among patients ≥ 65 years of age with Parkinson’s disease (from the National Inpatient Sample). Am J Cardiol. 2020;S0002-9149(20):30959.